Interleukin-1β and -10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 8, 2010, Pages 1443-1451

  Cheng, Hsin Hung ^a   Chang, Chi Sen ^b,c   Wang, Hung Jung ^a   Wang, Wen Ching ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

gastritis; gastroesophageal reflux disease; Helicobacter pylori; interleukin 10; interleukin 1

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GASTRITIS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TAIWAN; ASIAN; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ETHNOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER PYLORI; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; RISK; RISK ASSESSMENT; STATISTICAL MODEL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ESOPHAGITIS, PEPTIC; FEMALE; GASTRITIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-8; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954908689     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06310.x     Document Type: Article

References (50)

1. Kupiers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment. Pharmacol. Ther. 1999 13 (Suppl. 1 3 11.
2. WHO. IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: IARC 1994.
3. Logan RP, Gummett PA, Misiewicz JJ, Karim QN, Walker MM, Baron JH. One week eradication regimen for Helicobacter pylori. Lancet 1991 338 : 1249 1252.
4. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996 110 : 1244 1252.
5. el-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998 43 : 327 333.
6. Clark GW. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma. World J. Surg. 2003 27 : 994 998.
7. Dodds WJ, Dent J, Hogan WJ et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N. Engl. J. Med. 1982 307 : 1547 1552.
8. Loffeld RJ, Werdmuller BF, Kuster JG, Perez-Perez GI, Blaser MJ, Kuipers EJ. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000 62 : 95 9.
9. Queiroz DM, Guerra JB, Rocha GA et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004 127 : 73 9.
10. Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2000 14 : 45 51.
11. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am. J. Gastroenterol. 2002 97 : 2992 2997.
12. Fox JG, Beck P, Dangler CA et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat. Med. 2000 6 : 536 542.
13. D'Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, T cells and cytokines: the 'dangerous liaisons'. FEMS Immunol. Med. Microbiol. 2005 44 : 113 119.
14. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997 41 : 442 451.
15. Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2004 2 : 747 765.
16. Karttunen RA, Karttunen TJ, Yousfi MM, el-Zimaity HM, Graham DY, el-Zaatari FA. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol. 1997 32 : 22 7.
17. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J. Immunol. 1998 160 : 2401 2407.
18. Matsushima K, Baldwin ET, Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem. Immunol. 1992 51 : 236 265.
19. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001 48 : 743 747.
20. Peek RM Jr., Crabtree JE. Helicobacter infection and gastric neoplasia. J. Pathol. 2006 208 : 233 248.
21. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998 42 : 227 234.
22. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. The dual role of IL-10. Trends Immunol. 2003 24 : 36 43.
23. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000 55 : 1023 1027.
24. Lanas A, Garcia-Gonzalez MA, Santolaria S et al. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun. 2001 2 : 415 421.
25. Rad R, Dossumbekova A, Neu B et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004 53 : 1082 1089.
26. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 1992 22 : 396 402.
27. Hwang IR, Kodama T, Kikuchi S et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002 123 : 1793 1803.
28. El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003 124 : 1193 1201.
29. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int. J. Cancer 2003 104 : 617 623.
30. Sugimoto M, Furuta T, Shirai N et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J. Gastroenterol. Hepatol. 2007 22 : 1443 1449.
31. Gao L, Weck MN, Nieters A, Brenner H. Association between a pro-inflammatory genetic profile and the risk of chronic atrophic gastritis among older adults from Germany. Eur. J. Cancer 2009 45 : 428 434.
32. Zhang WH, Wang XL, Zhou J, An LZ, Xie XD. Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 2005 30 : 378 381.
33. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002 123 : 92 105.
34. Muramatsu A, Azuma T, Okuda T et al. Association between interleukin-1beta-511C/T polymorphism and reflux esophagitis in Japan. J. Gastroenterol. 2005 40 : 873 877.
35. Lai CH, Poon SK, Chen YC, Chang CS, Wang WC. Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease. Helicobacter 2005 10 : 577 585.
36. Kuo CH, Poon SK, Su YC, Su R, Chang CS, Wang WC. Heterogeneous Helicobacter pylori isolates from H. pylori-infected couples in Taiwan. J. Infect. Dis. 1999 180 : 2064 2068.
37. Poon SK, Chang CS, Su J et al. Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. Aliment. Pharmacol. Ther. 2002 16 : 291 296.
38. Lee JY, Kim HY, Kim KH et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett. 2005 225 : 207 214.
39. Lee WP, Tai DI, Lan KH et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 2005 11 : 6431 6441.
40. Johnson VJ, Yucesoy B, Luster MI. Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology. Cytokine 2004 27 : 135 141.
41. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 : 263 265.
42. Ando T, El-Omar EM, Goto Y et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006 55 : 158 164.
43. Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL- 1RN*1 (T1) haplotype may protect against the disease. Am. J. Gastroenterol. 2009 104 : 2704 2713.
44. Holtmann G, Adam B, Liebregts T. Review article: the patient with gastro-oesophageal reflux disease - lifestyle advice and medication. Aliment. Pharmacol. Ther. 2004 20 (Suppl. 8 24 7.
45. Wallace JL, Cucala M, Mugridge K, Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am. J. Physiol. 1991 261 : G559 64.
46. Rieder F, Cheng L, Harnett KM et al. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 2007 132 : 154 165.
47. Cao W, Cheng L, Behar J, Fiocchi C, Biancani P, Harnett KM. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2004 287 : G1131 9.
48. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996 87 : 2095 2147.
49. Sturlan S, Oberhuber G, Beinhauer BG et al. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis 2001 22 : 665 671.
50. Zambon CF, Basso D, Navaglia F et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005 29 : 141 152.